glp-1 before pregnancy Use of drugs early in should not cause alarm GLP-1 agonists' safety during pregnancy

It is intended to guide rational re-evaluation rather than to advocate indiscriminate revival of underexplored peptide systems

The prevalence of AD is 10% in people over 65 years of age and 40% in people over 85 years of age

While the potential cost of authorizing Medicare coverage of anti-obesity drugs has presented a barrier to enacting legislation to lift the prohibition, covering these drugs under Medicare for authorized uses has already catapulted these drugs to rank among the top-selling drugs covered by Part D, Medicares outpatient drug benefit program

Your doctor will help you map out realistic goals that make sense for you

Discontinuing the medication is known to lead to rapid weight regain, creating a significant burden of having to take weekly injections throughout the treatment period

2021 Jan;12(1):143-157